Efectividad del tratamiento tópico de la flebitis secundaria a la cateterización periféricauna revisión sistemática

  1. Martín Gil, Belén 1
  2. Fernández Castro, Mercedes 1
  3. López Vallecillo, María
  4. Peña García, Isabel
  1. 1 Hospital Universitario de Valladolid
    info

    Hospital Universitario de Valladolid

    Valladolid, España

    ROR https://ror.org/04fffmj41

Revista:
Enfermería global: revista electrónica trimestral de enfermería

ISSN: 1695-6141

Año de publicación: 2017

Volumen: 16

Número: 1

Páginas: 491-507

Tipo: Artículo

DOI: 10.6018/EGLOBAL.16.1.260411 DIALNET GOOGLE SCHOLAR lock_openDIGITUM editor

Otras publicaciones en: Enfermería global: revista electrónica trimestral de enfermería

Objetivos de desarrollo sostenible

Resumen

Background: Phlebitis is the most common complication induced by peripheral intravenous catheter.Aim: To assess the best available evidence concerning the effectiveness of topical therapies in patients with peripheral venous canulation who developed phlebitisMethod: The bibliographic search for clinical trials and sistematic reviews, published between 1995 and 2015, was carried out in the following databases Pubmed, Cinahl, Cochrane plus CUIDEN and BVS (Biblioteca Virtual en Salud), in english and spanish. Inclusion criteria were: adult inpatient with peripheral venous cateterization with continous or intermitent infusion, including all types of infusion therapy who developed any degree of superficial phlebitis. The quality of selected studies was assessed independently by peer reviewers using the Clinical Appraisal Skills Programme in its spanish version.Results: 11 studies were identified, 8 clinical trials and 3 sistematic reviews.  The efectiveness of topical phytotherapeutics: aloe vera, chamomilla recutita and notoginseny; heparinoid creams and heparin gels; anti-inflamatory as diclofenac, and vasodilators as nitroglycerin was analized, showing effectivity all of them.Conclusions: Aloe vera, notoginseny, diclofenac and heparine gel suggest a weak level of evidence and moderate grade of recommendation. Heparin gel is the only product provided by the Spanish Medicine Agency to treat post-infusion phlebitis, notoginseny is not marketed in Spain and diclofenac is an anti-inflammatory used for various pathologies. Deserves special attention of topical therapy with aloe vera but further studies are needed

Referencias bibliográficas

  • 1.Rojas-Sánchez L Z, Parra D I, Camargo-Figuera F A. Incidencia y factores asociados al desarrollo de flebitis: resultados del estudio piloto de una cohorte. Referencia 2015;IV(4):61-67, http://dx.doi.org/10.12707/RIII13141
  • 2.Mestre Roca G, Berbel Bertolo C, Tortajada Lopez P, Gallemi Samaranch G, Aguilar Ramírez M A, Caylà Buqueras J, et al. Assessing the influence of risk factors on rates and dynamics of peripheral vein phlebitis: An observational cohort study. Med Clin (Barc). 2012;139(5):185–191, http://dx.doi.org/10.1016/j.medcli.2011.12.021
  • 3.Cicolini G, Manzoli L, Simonetti V, Flacco ME, Comparcini D, Capasso L, et al. Phlebitis risk varies by peripheral venous catéter site and increases after 96 hours: a large multi-centre prospective study. J Adv Nurs. 2014 Nov;70(11):2539-49, http://dx.doi.org/10.1111/jan.12403
  • 4. Martínez JA, Piazuelo M, Almela M, Blecua P, Gallardo R, Rodríguez S, et al. Evaluation of add-on devices for the prevention of phlebitis and other complications associated with the use of peripheral catheters in hospitalised adults: a randomised controlled study. J Hosp Infect. 2009 Oct;73(2):135-42, http://dx.doi.org/10.1016/j.jhin.2009.06.031
  • 5.Hadaway L. Short peripheral intravenous catheters and infections. J Infus Nurs. 2012 Jul-Aug;35(4):230-40. DOI: 10.1097/NAN.0b013e31825af099.
  • 6.Marsh N, Mihala G, Ray-Barruel G2, Webster J, Wallis MC, Rickard CM. Inter-rater agreement on PIVC associated phlebitis signs, symtoms and scales. J Eval Clin Pract. 2015 Oct;21(5):893-9, http://dx.doi.org/10.1111/jep.12396
  • 7.Woody G, Davis BA. Increasing nurse competence in peripheral intravenous therapy. J Infus Nurs. 2013 Nov-Dec;36(6):413-9. DOI: 10.1097/NAN.0000000000000013.
  • 8.Ferrer C, Almirante B. Venous catheter-related infections. Enferm Infecc Microbiol Clin. 2014 Feb;32(2):115-24, http://dx.doi.org/10.1016/j.eimc.2013.12.002
  • 9.González López JL, Arribi Vilela A, Fernández del Palacio E, Olivares Corral J, Benedicto Martí C, Herrera Portal P. Indwell times, complications and costs of open vs closed safety peripheral intravenous catheters: a randomized study. J Hosp Infect. 2014 Feb;86(2):117-26, http://dx.doi.org/10.1016/j.jhin.2013.10.008
  • 10.Stuart RL, Cameron DR, Scott C, Kotsanas D, Grayson ML, Korman TM, et al. Peripheral intravenous catheter-associated Staphylococcus aureus bacteraemia: more than 5 years of prospective data from two tertiary health services. Med J Aust. 2013 Jun 3;198(10):551-3, http://dx.doi.org/10.5694/mja12.11699
  • 11.Ferrete-Morales C, Vázquez-Pérez MA, Sánchez-Berna M, Gilabert-CerroI, Corzo-Delgado JE, Pineda-Vergara JA, et al. Incidence of phlebitis due to peripherally inserted venous catheters: impact of a catheter management protocol. Enferm Clin. 2010 Jan-Feb;20(1):3-9, http://dx.doi.org/10.1016/j.enfcli.2009.10.001
  • 12.Bulechek GM, Butcher HK, Dochterman JM, editoras. Clasificación de intervenciones de enfermería (NIC). 5ª ed. Madrid: Elsevier Mostby; 2013, p. 764.
  • 13.Smith SE, Duell DJ, Martin BC. Técnicas de enfermería clínica. De las técnicas básicas a las avanzadas. Vol II. 7ª ed. Madrid: Pearson; 2009, p. 1097.
  • 14.Alexander M, Corrigan A, Gorskil L, Hankins J, Perucca R. Infusion nursing and evidence-based approach. 3ª ed. St Luis, Missouri: Saunder Elsevier, 2010, p. 475.
  • 15.Ingram P, Lavery I. Peripheral intravenous therapy: key risks and implications for practice. Nurs Stand. 2005;19(46):55-64.
  • 16.Tjon JA, Ansani NT. Transdermal nitroglycerin for the prevention of intravenous infusion failure due to phlebitis and extravasation. Ann Pharmacother. 2000;34(10):1189-1192
  • 17.Grupo de trabajo de la Guía de Práctica Clínica sobre Terapia Intravenosa con Dispositivos no Permanentes en Adultos. Guía de Práctica Clínica sobre Terapia Intravenosa con Dispositivos no Permanentes en Adultos. Ministerio de Sanidad, Servicios Sociales e Igualdad. Agencia de Evaluación de Tecnologías Sanitarias de Andalucía (AETSA); 2014. Guías de Práctica Clínica en el SNS.
  • 18.Guías CASPe de Lectura Crítica de la Literatura Médica CASPe 2014. [consulta 11 En 2016]. Disponible en: http://www.redcaspe.org.
  • 19.Joanna Briggs Institute JBI CONNECT Espa˜na [Internet].Madrid: Centre col.laborador espanyol del JBI; 20014 [consulta 11 En 2016]. Disponible en: http://joannabriggs.org/jbi-approach.html#tabbed-nav=Grades-of-Recommendation.
  • 20.Reis PED Dos, Carvalho EC de, Bueno PCP, Bastos JK. Clinical application of Chamomilla recutita in phlebitis: dose response curve study. Rev Lat Am Enfermagem. 2011 ;19 (1):3–10. DOI: 10.1590/S0104-11692011000100002
  • 21.Gouping Z, Wan-Er T, Xue-Ling W, Min-Qian X, Kun F, Turale S, et al. Notoginseny cream in the treatment of phlebitis. J Infus Nurs. 2003 ;26 (1):49–54. DOI: 10.1097/00129804-200301000-00007
  • 22.Becherucci A, Bagilet D, Marenghini J, Diab M, Biancardi H. [Effect of topical and oral diclofenac on superficial thrombophlebitis caused by intravenous infusion]. Med Clin (Barc). 2000 Mar 18;114(10):371-3. DOI:10.1016/S0025-7753(00)71300-5
  • 23.Vilardell M, Sabat D, Arnaiz JA, Bleda MJ, Castel JM, Laporte JR, Vallvé C. Topical heparin for the treatment of acute superficial phlebitis secondary to indwelling intravenous catheter. A double-blind, randomized, placebo-controlled trial. Eur J Clin Pharmacol. 1999 Feb;54(12):917-21. DOI: 10.1007/s002280050575
  • 24.De Sanctis MT, Cesarone MR, Incandela L, Belcaro G, Griffin M. Treatment of superficial vein thrombophlebitis of the arm with Essaven gel--a placebo-controlled, randomized study. Angiology. 2001 Dec;52 Suppl 3:S63-7. DOI: 10.1177/000331970105200312.
  • 25.Ruiz Trillo C, Borrero Esteban MP. Tratamientos aplicados a la Flebitis posperfusión. Rev ROL Enferm.2006; 29(2): 55-60.
  • 26.Ng IHL, Jabin K. Best Treatment Modality for Superficial Phlebitis. Ann Acad Med Singapore. 2010 Nov;39(11):S2010 http://www.annals.edu.sg/pdf/39VolNo11SupplNov2010/V39N11%28Suppl%29.pdf
  • 27.Córcoles MP, Ruiz T, García D. Flebitis postpunción. Rev ROL Enferm.1996 Sept; 217:13-16
  • 28.Zheng GH, Yang L, Chen HY, Chu JF, Mei L. Aloe vera for prevention and treatment of infusion phlebitis. Cochrane Database Syst Rev 2014; 6: CD009162. DOI:10.1002/14651858.CD009162.pub2.
  • 29.Reis PED Dos, Silveira RC, Vasques CI, Carvalho EC de. Pharmacological interventions to treat phlebitis: systematic review. J Infus Nurs. 2009; 32(2): 74–9. DOI:10.1097/NAN.0b013e318198d497. 30.Di Nisio M, Peinemann F, Porreca E, Rutjes AW. Treatment for superficial infusion thrombophlebitis of the upper extremity. Cochrane Database Syst Rev. 2015 Nov 20;11:CD011015. DOI: 10.1002/14651858.CD011015.pub2.
Fuente de los datos: Dialnet